NEUP - Neuphoria Company Aggregate Debts
The development of psychiatric drugs is constrained by strict FDA oversight and patent law. A narrow portfolio of CNS molecules creates binary risks for the business of Neuphoria Therapeutics Inc. (NEUP). The team relies on an ethical culture and an ambitious mission. A substantial amount of borrowed funds demonstrates the dynamics of debt obligations, where the latest value is recorded as 0.00, helping to assess the issuer's investment potential.
%3A%20Company%20Debts&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261031&filename=GURU_Markets_-_NEUP_-_Neuphoria-Therapeutics-Inc._-_Company-Debts "Aggregate Debt Obligations: bionomics.com.au (NEUP) for 12/25/2024 - 10/31/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for Neuphoria Therapeutics Inc. (NEUP)
- current quotes and average value forecast:
- market capitalization statistics:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio Neuphoria Therapeutics Inc.|NEUP - Long-Term Debt to Capital|Current Liabilities to Capital bionomics.com.au|NEUP - Company Total Debt|Debts to Book Capitalization Neuphoria|NEUP - Company Long-Term Debt|Current Liabilities Neuphoria Therapeutics|Intermediate Coverage Ratio bionomics.com.au
- earnings and valuation multiples information:
Summary company analytics:NEUP Neuphoria Therapeutics, Inc.
Fundamental asset screening requires a precise analysis of the capital structure to assess the issuer's financial stability. The organization's debt profile visualizes the total volume of borrowed obligations, allowing the investor to weigh the pace of fundraising against the risks of zero revenue and the potential failure of clinical trials for Neuphoria Therapeutics Inc. (NEUP) drugs, which critically impacts the preservation of invested capital.
Competitors of Neuphoria Therapeutics Inc.
BIIB - Company Cumulative Debt|Neurocrine Biosciences - Company Total Debt|Company Aggregate Debts regencellbioscience.com RGC|AXSM - Company Debts|Aggregate Debt Obligations ACAD (ACADIA Pharma)|Xenon Pharmaceuticals Inc (XENE) - Company Debts|Company Cumulative Debt Viking Therapeutics Corp (VKTX)|Company Debts Supernus Pharmaceuticals|Company Aggregate Debt CPRX (catalystpharma.com)|Company Aggregate Debts DNLI|HRMY - Company Cumulative Debt|Biohaven Pharmaceutical - Company Total Debt|Company Aggregate Debts Amylyx Corp AMLX|TRVI - Company Debts|Company Aggregate Indebtedness PRAX|AVXL: Company Aggregate Debts|CeriBell Inc - Aggregate Debt Obligations|Company Debts Prothena Corporation|Company Cumulative Debt Alector Therapeutics ALEC|Company Debts Annexon, Inc. (ANNX)|OMER (omeros.com) - Aggregate Debt Obligations|Company Aggregate Debts NGNE (Neurogene)|Company Total Debt Obligations AC Immune S.A. (ACIU)|Voyager Pharma - Company Aggregate Debts|NMRA - Company Aggregate Debts|SCLX (Scilex Holding Company) - Company Total Debt|tevogen.com - Aggregate Debt Obligations|Company Total Debt ACOG|CGTX (Cognition Therapeutics Inc.) - Company Cumulative Indebtedness|Company Aggregate Debts IKT|SAVA (Cassava Pharma) - Aggregate Debt Obligations|Company Aggregate Debts ASRT (Assertio)|Coya Therapeutics Inc (COYA) - Company Cumulative Debt|VTGN - Company Debts|Aggregate Debt Obligations OVID (Ovid Therapeutics Inc.)|ABOS: Company Aggregate Debts|CervoMed Corporation (CRVO) - Company Aggregate Debts|Company Debts Alterity Therapeutics Ltd.|Clene Nanomedicine - Company Aggregate Indebtedness|Company Aggregate Debts PEPG|JUNS - Company Cumulative Debt|Relmada - Company Total Debt|Company Aggregate Debts Annovis Bio Corporation ANVS|GRCE: Company Total Debt|fireflyneuro.com - Company Cumulative Indebtedness|KLTO: Company Aggregate Debts|NRSN - Company Total Debt Obligations|RVPH (Reviva Pharmaceuticals Holdings) - Company Aggregate Debts|Company Total Debt MetaVia, Inc. (MTVA)|Company Debts NeurAxis, Inc. (NRXS)|Company Total Debt Obligations heliusmedical.com|Passage Bio - Company Total Debt|Aggregate Debt Obligations NERV|Athira - Company Aggregate Debts|Company Total Debt Obligations Addex ADXN|alzamend.com (ALZN) - Company Debts|Company Aggregate Debt CYCN|PTIX (Protagenic Therapeutics Inc.) - Company Aggregate Debts|Company Total Debt Pasithea (KTTA)|Company Total Debt CRGT (Cortigent, Inc.)|Company Total Debt Obligations Avenue Therapeutics Inc|Company Debts Brainstorm Cell BCLI|CARA: Company Aggregate Debt|Chromocell Therapeutics Corp. - Company Aggregate Debts|Company Cumulative Debt Eliem Therapeutics|ITCI (intracellulartherapies.com) - Company Total Debt|Longboard (LBPH) - Company Aggregate Debts|Company Debts Marinus Pharmaceuticals|nkgenbiotech.com - Company Aggregate Indebtedness|Company Debts NeuroBo Pharmaceuticals, Inc. (NRBO)|Sage Therapeutics Inc. - Company Aggregate Debt|Company Aggregate Debts SNPX (Neurotrope)|Trevena Inc (TRVN) - Company Cumulative Debt|VIGL: Company Total Debt|WENA - Company Aggregate Debts|Cerevel Therapeutics, Inc. (CERE) - Company Debts